Clinical trial NCT05530239 - References

Sickle Cell Disease — Nano-rheological Biomarkers for Patients With Sickle Cell Disease (SCD) Versus Control Subjects (Other Constitutional Red Blood Cell Diseases and Healthy Subjects)

Citation(s)

•   Arlet JB
  [A new therapeutic era in sickle cell disease]. Rev Med Interne. 2017 Sep;38(9):569-571. doi: 10.1016/j.revmed.2017.05.006. Epub 2017 Jun 16. French.
•   Ataga KI, Kutlar A, Kanter J
  Crizanlizumab in Sickle Cell Disease. N Engl J Med. 2017 May 4;376(18):1796. doi: 10.1056/NEJMc1703162.
•   Baez S, Kaul DK, Nagel RL
  Microvascular determinants of blood flow behavior and HbSS erythrocyte plugging in microcirculation. Blood Cells. 1982;8(1):127-37.
•   Ballas SK, Barton FB, Waclawiw MA, Swerdlow P, Eckman JR, Pegelow CH, Koshy M, Barton BA, Bonds DR
  Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes. 2006 Aug 31;4:59.
•   Ballas SK
  The Evolving Pharmacotherapeutic Landscape for the Treatment of Sickle Cell Disease. Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020010. doi: 10.4084/MJHID.2020.010. eCollection 2020. Review.
•   Banerjee R, Nageshwari K, Puniyani RR
  The diagnostic relevance of red cell rigidity. Clin Hemorheol Microcirc. 1998 Sep;19(1):21-4.
•   Bartolucci P, Brugnara C, Teixeira-Pinto A, Pissard S, Moradkhani K, Jouault H, Galacteros F
  Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis. Blood. 2012 Oct 11;120(15):3136-41. doi: 10.1182/blood-2012-04-424184. Epub 2012 Aug 23. Erratum in: Blood. 2014 Mar 20;123(12):1972.
•   Briole A, Podgorski T, Abou B
  Molecular rotors as intracellular probes of red blood cell stiffness. Soft Matter. 2021 May 5;17(17):4525-4537. doi: 10.1039/d1sm00321f.
•   Connes P, Alexy T, Detterich J, Romana M, Hardy-Dessources MD, Ballas SK
  The role of blood rheology in sickle cell disease. Blood Rev. 2016 Mar;30(2):111-8. doi: 10.1016/j.blre.2015.08.005. Epub 2015 Aug 28. Review.
•   Du E, Diez-Silva M, Kato GJ, Dao M, Suresh S
  Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis. Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1422-7. doi: 10.1073/pnas.1424111112. Epub 2015 Jan 20.
•   Faivre M, Renoux C, Bessaa A, Da Costa L, Joly P, Gauthier A, Connes P
  Mechanical Signature of Red Blood Cells Flowing Out of a Microfluidic Constriction Is Impacted by Membrane Elasticity, Cell Surface-to-Volume Ratio and Diseases. Front Physiol. 2020 Jun 12;11:576. doi: 10.3389/fphys.2020.00576. eCollection 2020.
•   Gladwin MT, Vichinsky E
  Pulmonary complications of sickle cell disease. N Engl J Med. 2008 Nov 20;359(21):2254-65. doi: 10.1056/NEJMra0804411. Review.
•   Gossett DR, Tse HT, Lee SA, Ying Y, Lindgren AG, Yang OO, Rao J, Clark AT, Di Carlo D
  Hydrodynamic stretching of single cells for large population mechanical phenotyping. Proc Natl Acad Sci U S A. 2012 May 15;109(20):7630-5. doi: 10.1073/pnas.1200107109. Epub 2012 Apr 30.
•   Guo Q, Duffy SP, Matthews K, Santoso AT, Scott MD, Ma H
  Microfluidic analysis of red blood cell deformability. J Biomech. 2014 Jun 3;47(8):1767-76. doi: 10.1016/j.jbiomech.2014.03.038. Epub 2014 Apr 5.
•   Hamideh D, Alvarez O
  Sickle cell disease related mortality in the United States (1999-2009). Pediatr Blood Cancer. 2013 Sep;60(9):1482-6. doi: 10.1002/pbc.24557. Epub 2013 Apr 23.
•   Holmes D, Whyte G, Bailey J, Vergara-Irigaray N, Ekpenyong A, Guck J, Duke T
  Separation of blood cells with differing deformability using deterministic lateral displacement(†). Interface Focus. 2014 Dec 6;4(6):20140011. doi: 10.1098/rsfs.2014.0011.
•   Kaul DK, Fabry ME, Windisch P, Baez S, Nagel RL
  Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics. J Clin Invest. 1983 Jul;72(1):22-31.
•   Kaul DK, Fabry ME
  In vivo studies of sickle red blood cells. Microcirculation. 2004 Mar;11(2):153-65. Review.
•   Kuimova MK, Yahioglu G, Levitt JA, Suhling K
  Molecular rotor measures viscosity of live cells via fluorescence lifetime imaging. J Am Chem Soc. 2008 May 28;130(21):6672-3. doi: 10.1021/ja800570d. Epub 2008 May 6.
•   Lanzkron S, Carroll CP, Haywood C Jr
  Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. Public Health Rep. 2013 Mar-Apr;128(2):110-6.
•   Lipowsky HH, Cram LE, Justice W, Eppihimer MJ
  Effect of erythrocyte deformability on in vivo red cell transit time and hematocrit and their correlation with in vitro filterability. Microvasc Res. 1993 Jul;46(1):43-64.
•   Lu X, Chaudhury A, Higgins JM, Wood DK
  Oxygen-dependent flow of sickle trait blood as an in vitro therapeutic benchmark for sickle cell disease treatments. Am J Hematol. 2018 Oct;93(10):1227-1235. doi: 10.1002/ajh.25227. Epub 2018 Aug 21.
•   Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease
  A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971.
•   Piel FB, Steinberg MH, Rees DC
  Sickle Cell Disease. N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865. Review.
•   Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, Caccavelli L, Neven B, Bourget P, El Nemer W, Bartolucci P, Weber L, Puy H, Meritet JF, Grevent D, Beuzard Y, Chrétien S, Lefebvre T, Ross RW, Negre O, Veres G, Sandler L, Soni S, de Montalembert M, Blanche S, Leboulch P, Cavazzana M
  Gene Therapy in a Patient with Sickle Cell Disease. N Engl J Med. 2017 Mar 2;376(9):848-855. doi: 10.1056/NEJMoa1609677.
•   Telen MJ
  Developing new pharmacotherapeutic approaches to treating sickle-cell disease. ISBT Sci Ser. 2017 Feb;12(1):239-247. doi: 10.1111/voxs.12305. Epub 2016 Nov 15.
•   Tomaiuolo G
  Biomechanical properties of red blood cells in health and disease towards microfluidics. Biomicrofluidics. 2014 Sep 17;8(5):051501. doi: 10.1063/1.4895755. eCollection 2014 Sep. Review.
•   Vargas FF, Blackshear GL
  Vascular resistance and transit time of sickle red blood cells. Blood Cells. 1982;8(1):139-45.
•   Woodcock EM, Girvan P, Eckert J, Lopez-Duarte I, Kubánková M, van Loon JJWA, Brooks NJ, Kuimova MK
  Measuring Intracellular Viscosity in Conditions of Hypergravity. Biophys J. 2019 May 21;116(10):1984-1993. doi: 10.1016/j.bpj.2019.03.038. Epub 2019 Apr 8.
•   Yaginuma T, Oliveira MS, Lima R, Ishikawa T, Yamaguchi T
  Human red blood cell behavior under homogeneous extensional flow in a hyperbolic-shaped microchannel. Biomicrofluidics. 2013 Sep 24;7(5):54110. doi: 10.1063/1.4820414. eCollection 2013.

Single-center Pilot Study: Nano-rheological Biomarkers for Patients With Sickle Cell Disease (SCD) Versus Control Subjects (Other Constitutional Red Blood Cell Diseases and Healthy Subjects)

Details for clinical trial NCT05530239